{"name":"Laboratorios Silanes S.A. de C.V.","slug":"laboratorios-silanes-s-a-de-c-v","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":8,"colorKey":"oncology","drugs":[{"name":"Celecoxib + Vitamin B fixed dose","genericName":"Celecoxib + Vitamin B fixed dose","slug":"celecoxib-vitamin-b-fixed-dose","indication":"Osteoarthritis","status":"phase_3"},{"name":"Dexketoprofen/Vitamin B","genericName":"Dexketoprofen/Vitamin B","slug":"dexketoprofen-vitamin-b","indication":"Acute and chronic pain conditions","status":"phase_3"},{"name":"Etoricoxib + Betamethasone fixed dose","genericName":"Etoricoxib + Betamethasone fixed dose","slug":"etoricoxib-betamethasone-fixed-dose","indication":"Rheumatoid arthritis","status":"phase_3"},{"name":"Fixed Dose Etoricoxib + Betamethasone","genericName":"Fixed Dose Etoricoxib + Betamethasone","slug":"fixed-dose-etoricoxib-betamethasone","indication":"Rheumatoid arthritis","status":"phase_3"},{"name":"Celecoxib + Acetaminohen","genericName":"Celecoxib + Acetaminohen","slug":"celecoxib-acetaminohen","indication":"Acute and chronic pain management","status":"phase_3"},{"name":"Etoricoxib + Cyanocobalamin fixed dose","genericName":"Etoricoxib + Cyanocobalamin fixed dose","slug":"etoricoxib-cyanocobalamin-fixed-dose","indication":"Inflammatory pain conditions (likely osteoarthritis, rheumatoid arthritis, or musculoskeletal pain with concurrent B12 deficiency)","status":"phase_3"},{"name":"Etoricoxib fixed dose","genericName":"Etoricoxib fixed dose","slug":"etoricoxib-fixed-dose","indication":"Rheumatoid arthritis","status":"phase_3"},{"name":"Monotherapy Etoricoxib","genericName":"Monotherapy Etoricoxib","slug":"monotherapy-etoricoxib","indication":"Rheumatoid arthritis","status":"phase_3"}]},{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"cardiovascular","drugs":[{"name":"Etoricoxib + Tizanidine fixed dose","genericName":"Etoricoxib + Tizanidine fixed dose","slug":"etoricoxib-tizanidine-fixed-dose","indication":"Acute musculoskeletal pain with muscle spasm","status":"phase_3"},{"name":"Ibuprofen + Loratadine fixed dose","genericName":"Ibuprofen + Loratadine fixed dose","slug":"ibuprofen-loratadine-fixed-dose","indication":"Pain and inflammation associated with allergic conditions","status":"phase_3"},{"name":"Celecoxi + Acetaminophen","genericName":"Celecoxi + Acetaminophen","slug":"celecoxi-acetaminophen","indication":"Moderate to severe acute pain","status":"phase_3"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"infectious","drugs":[{"name":"Losartan + hydrochlorothiazide in fixed dose","genericName":"Losartan + hydrochlorothiazide in fixed dose","slug":"losartan-hydrochlorothiazide-in-fixed-dose","indication":"Hypertension (essential hypertension)","status":"phase_3"},{"name":"Losartan/Chlorthalidone in fixed dose","genericName":"Losartan/Chlorthalidone in fixed dose","slug":"losartan-chlorthalidone-in-fixed-dose","indication":"Hypertension (essential hypertension management)","status":"phase_3"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"rare","drugs":[{"name":"Sibutramine-Metformin","genericName":"Sibutramine-Metformin","slug":"sibutramine-metformin","indication":"Obesity with or without type 2 diabetes mellitus","status":"phase_3"},{"name":"metformin/glimepiride combination","genericName":"metformin/glimepiride combination","slug":"metformin-glimepiride-combination","indication":"Type 2 diabetes mellitus","status":"marketed"}]},{"name":"Dermatology","slug":"dermatology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Desloratadine / Betamethasone in fixed dose","genericName":"Desloratadine / Betamethasone in fixed dose","slug":"desloratadine-betamethasone-in-fixed-dose","indication":"Allergic rhinitis","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"neuroscience","drugs":[{"name":"DMMET-01","genericName":"DMMET-01","slug":"dmmet-01","indication":"Other","status":"phase_2"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"respiratory","drugs":[{"name":"Pregabalin + Vitamin B fixed dose","genericName":"Pregabalin + Vitamin B fixed dose","slug":"pregabalin-vitamin-b-fixed-dose","indication":"Neuropathic pain (diabetic peripheral neuropathy, postherpetic neuralgia, or other peripheral neuropathies)","status":"phase_3"}]}],"pipeline":[{"name":"Celecoxib + Vitamin B fixed dose","genericName":"Celecoxib + Vitamin B fixed dose","slug":"celecoxib-vitamin-b-fixed-dose","phase":"phase_3","mechanism":"Celecoxib selectively inhibits cyclooxygenase-2 (COX-2) to reduce inflammation and pain, while B vitamins support metabolic and neurological function.","indications":["Osteoarthritis","Rheumatoid arthritis","Acute pain conditions","Musculoskeletal pain with neuropathic component"],"catalyst":""},{"name":"Desloratadine / Betamethasone in fixed dose","genericName":"Desloratadine / Betamethasone in fixed dose","slug":"desloratadine-betamethasone-in-fixed-dose","phase":"phase_3","mechanism":"Desloratadine blocks histamine H1 receptors to reduce allergic symptoms, while betamethasone is a corticosteroid that suppresses inflammatory and immune responses.","indications":["Allergic rhinitis","Allergic dermatitis","Urticaria"],"catalyst":""},{"name":"Dexketoprofen/Vitamin B","genericName":"Dexketoprofen/Vitamin B","slug":"dexketoprofen-vitamin-b","phase":"phase_3","mechanism":"Dexketoprofen inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis and inflammation, while vitamin B provides nutritional support and may enhance analgesic efficacy.","indications":["Acute and chronic pain conditions","Inflammatory conditions (arthritis, musculoskeletal pain)"],"catalyst":""},{"name":"Etoricoxib + Betamethasone fixed dose","genericName":"Etoricoxib + Betamethasone fixed dose","slug":"etoricoxib-betamethasone-fixed-dose","phase":"phase_3","mechanism":"Etoricoxib selectively inhibits COX-2 to reduce inflammation and pain, while betamethasone provides additional anti-inflammatory and immunosuppressive effects via glucocorticoid receptor activation.","indications":["Rheumatoid arthritis","Osteoarthritis","Ankylosing spondylitis","Other inflammatory joint disorders"],"catalyst":""},{"name":"Etoricoxib + Tizanidine fixed dose","genericName":"Etoricoxib + Tizanidine fixed dose","slug":"etoricoxib-tizanidine-fixed-dose","phase":"phase_3","mechanism":"Etoricoxib selectively inhibits COX-2 to reduce inflammation and pain, while tizanidine acts as a central alpha-2 adrenergic agonist to relieve muscle tension.","indications":["Acute musculoskeletal pain with muscle spasm","Chronic pain conditions with associated muscle tension"],"catalyst":""},{"name":"Fixed Dose Etoricoxib + Betamethasone","genericName":"Fixed Dose Etoricoxib + Betamethasone","slug":"fixed-dose-etoricoxib-betamethasone","phase":"phase_3","mechanism":"Etoricoxib selectively inhibits COX-2 to reduce inflammation and pain, while betamethasone provides additional anti-inflammatory and immunosuppressive effects via glucocorticoid receptor activation.","indications":["Rheumatoid arthritis","Osteoarthritis","Ankylosing spondylitis","Other inflammatory joint disorders"],"catalyst":""},{"name":"Ibuprofen + Loratadine fixed dose","genericName":"Ibuprofen + Loratadine fixed dose","slug":"ibuprofen-loratadine-fixed-dose","phase":"phase_3","mechanism":"Ibuprofen reduces inflammation and pain by inhibiting cyclooxygenase enzymes, while loratadine blocks histamine H1 receptors to relieve allergic symptoms.","indications":["Pain and inflammation associated with allergic conditions","Headache, fever, and minor aches with concurrent allergic symptoms"],"catalyst":""},{"name":"Celecoxi + Acetaminophen","genericName":"Celecoxi + Acetaminophen","slug":"celecoxi-acetaminophen","phase":"phase_3","mechanism":"Celecoxib selectively inhibits COX-2 to reduce inflammation and pain, while acetaminophen inhibits prostaglandin synthesis to provide additional analgesic and antipyretic effects.","indications":["Moderate to severe acute pain","Postoperative pain","Musculoskeletal pain conditions"],"catalyst":""},{"name":"Celecoxib + Acetaminohen","genericName":"Celecoxib + Acetaminohen","slug":"celecoxib-acetaminohen","phase":"phase_3","mechanism":"Celecoxib selectively inhibits COX-2 to reduce inflammation and pain, while acetaminophen inhibits prostaglandin synthesis to provide additional analgesic and antipyretic effects.","indications":["Acute and chronic pain management","Inflammatory conditions (e.g., osteoarthritis, rheumatoid arthritis)"],"catalyst":""},{"name":"DMMET-01","genericName":"DMMET-01","slug":"dmmet-01","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Etoricoxib + Cyanocobalamin fixed dose","genericName":"Etoricoxib + Cyanocobalamin fixed dose","slug":"etoricoxib-cyanocobalamin-fixed-dose","phase":"phase_3","mechanism":"Etoricoxib selectively inhibits COX-2 to reduce inflammation and pain, while cyanocobalamin (vitamin B12) supports neurological function and red blood cell formation.","indications":["Inflammatory pain conditions (likely osteoarthritis, rheumatoid arthritis, or musculoskeletal pain with concurrent B12 deficiency)"],"catalyst":""},{"name":"Etoricoxib fixed dose","genericName":"Etoricoxib fixed dose","slug":"etoricoxib-fixed-dose","phase":"phase_3","mechanism":"Etoricoxib selectively inhibits cyclooxygenase-2 (COX-2) to reduce prostaglandin production and inflammation.","indications":["Rheumatoid arthritis","Osteoarthritis","Acute pain","Ankylosing spondylitis"],"catalyst":""},{"name":"Losartan + hydrochlorothiazide in fixed dose","genericName":"Losartan + hydrochlorothiazide in fixed dose","slug":"losartan-hydrochlorothiazide-in-fixed-dose","phase":"phase_3","mechanism":"Losartan blocks angiotensin II receptors to reduce vasoconstriction, while hydrochlorothiazide promotes sodium and water excretion to lower blood volume, together reducing blood pressure.","indications":["Hypertension (essential hypertension)","Reduction of cardiovascular morbidity and mortality in hypertensive patients at high risk"],"catalyst":""},{"name":"Losartan/Chlorthalidone in fixed dose","genericName":"Losartan/Chlorthalidone in fixed dose","slug":"losartan-chlorthalidone-in-fixed-dose","phase":"phase_3","mechanism":"Losartan blocks angiotensin II receptors to lower blood pressure, while chlorthalidone is a thiazide-like diuretic that reduces fluid volume and sodium reabsorption.","indications":["Hypertension (essential hypertension management)"],"catalyst":""},{"name":"Monotherapy Etoricoxib","genericName":"Monotherapy Etoricoxib","slug":"monotherapy-etoricoxib","phase":"phase_3","mechanism":"Etoricoxib selectively inhibits cyclooxygenase-2 (COX-2) to reduce prostaglandin production and inflammation.","indications":["Rheumatoid arthritis","Osteoarthritis","Acute pain","Ankylosing spondylitis"],"catalyst":""},{"name":"Pregabalin + Vitamin B fixed dose","genericName":"Pregabalin + Vitamin B fixed dose","slug":"pregabalin-vitamin-b-fixed-dose","phase":"phase_3","mechanism":"Pregabalin binds to voltage-gated calcium channels to reduce neurotransmitter release, while B vitamins support nerve function and myelin integrity.","indications":["Neuropathic pain (diabetic peripheral neuropathy, postherpetic neuralgia, or other peripheral neuropathies)","Generalized anxiety disorder","Partial-onset seizures"],"catalyst":""},{"name":"Sibutramine-Metformin","genericName":"Sibutramine-Metformin","slug":"sibutramine-metformin","phase":"phase_3","mechanism":"Sibutramine-Metformin is a combination drug that suppresses appetite through norepinephrine reuptake inhibition while improving insulin sensitivity and glucose metabolism.","indications":["Obesity with or without type 2 diabetes mellitus","Weight management in patients with metabolic syndrome"],"catalyst":""},{"name":"metformin/glimepiride combination","genericName":"metformin/glimepiride combination","slug":"metformin-glimepiride-combination","phase":"marketed","mechanism":"Metformin reduces hepatic glucose production and improves insulin sensitivity, while glimepiride stimulates pancreatic beta cells to increase insulin secretion, together lowering blood glucose in type 2 diabetes.","indications":["Type 2 diabetes mellitus"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTFBGbU14Y1pxeFdhM2tBakxVLTJTTFRsMzNIeDk4Sm94cDR2Q1U1aFNKNzRBSWZJcHpvWThTLTlpXzZWck5ZYTJ6SnliRTlNVnpfc0JKUG0wZzJ1Zm9Zazl5QngwOVB2Njhtd1ZLRHNGZlVyX2M1T3h3?oc=5","date":"2025-09-25","type":"pipeline","source":"Straits Research","summary":"Non-Opioid Pain Management Market Size, Share, Players & Trends by 2034 - Straits Research","headline":"Non-Opioid Pain Management Market Size, Share, Players & Trends by 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAJBVV95cUxNVkpQY0JPQ1YzemE1MEtvNkZkbDRHNExfdE1ibkU2b2JkZ1YtUnhmRWc5NFB6eFlGbTlSVGYwTlZ3Mnloa0dDZ005OUt4eE9GOXBvWGNfZW9RV2pyc1lIckdNWHM0VGhLS2FWTF9zcGVBQlUwMVZmSGRBSktFRUhxYmoyZjdlX2JKNnZLUDRncHBQalN3RDdSYkduSU5WaUxyaER5MTBDaXY1b3RjQUJHSXZMMkVBZDMxaUdVNnNMNFpISnlGejh5V0FBUHBLaWtsQmkzUWtlMXpTekw2U3FHeDJycEdUeTdjZTJaUmdGM283dVpBVWhyblBNdDRSeTJKVl83OV9TV0ZkMDdVVF9KUWpNb25xa2duc2VzQ2JfN1NEc2tKS3F1WHMtQ0JZV3F0NUlYYg?oc=5","date":"2021-04-05","type":"regulatory","source":"Business Wire","summary":"Rare Disease Therapeutics, Inc. Announces New Expanded FDA Approved Indication for Antivenom ANAVIP - Business Wire","headline":"Rare Disease Therapeutics, Inc. Announces New Expanded FDA Approved Indication for Antivenom ANAVIP","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTE9GVUxnQ0x3cTl3Y0VKZ3luTTI1dEhsTHJNSHBzYnU5eDI2eWlNMHJOLTFWWXpXUGdOWnQ1MGd1QnlQZWo0NHZrM3RXcUQ0bXQzLVE?oc=5","date":"2012-10-24","type":"pipeline","source":"nature.com","summary":"Antimicrobial peptides from arachnid venoms and their microbicidal activity in the presence of commercial antibiotics - nature.com","headline":"Antimicrobial peptides from arachnid venoms and their microbicidal activity in the presence of commercial antibiotics","sentiment":"neutral"}],"patents":[],"drugCount":18,"phaseCounts":{"phase_3":16,"phase_2":1,"marketed":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}